Transforming growth factor β family, insulin-derived GFs (insulin-like growth factor 1, IGF-1 and insulin-like growth factor 2, IGF-2), basic fibroblast growth factor (bFGF), and neurotrophins (nerve growth factor, NGF; brain-derived growth factor, BDGF; glial-derived neurotrophic factor, GDNF) all participate in neurogenesis and neurodevelopment and may be considered as potential targets for AD treatment [135, 136]. The gene discussed is IGF1; the disease is Alzheimer disease.